stockrowCarlsmed, Inc. (CARL) vs National Research Corporation (NRC)
- Carlsmed, Inc. CARL 14.42 −5.87%
- National Research Corporation NRC 25.83 +1.37%
Carlsmed, Inc. and National Research Corporation are both Health Information Services companies. National Research Corporation is the larger, with a market value of $563.6M against $418.3M — 1.3× the size. Carlsmed, Inc. has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 87.6×. Carlsmed, Inc. grew revenue faster over the last twelve months: 81.1% against 3.37%. National Research Corporation has the higher net margin (0.00% vs −57.4%) and the higher return on invested capital (11.6% vs −234.5%). Across the 16 metrics below, National Research Corporation leads on 12 and Carlsmed, Inc. on 4.
Valuation
Profitability
| Metric | CARL | NRC | Health Information Services median |
|---|---|---|---|
| Gross margin | 76.63% | 60.69% | 59.61% |
| Operating margin | (61.09%) | 11.06% | (10.54%) |
| Net margin | (57.42%) | 0.00% | (16.14%) |
| Free cash flow margin | (56.36%) | 12.83% | 0.00% |
| Return on equity | (6,196.93%) | 0.00% | (3.15%) |
| Return on assets | (42.39%) | 0.00% | (5.62%) |
| Return on invested capital | (234.53%) | 11.64% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack